New study could make it much easier for physicians to use the genetic profile of a patient’s tumor to pick the chemotherapy treatment with the fewest side effects and best chance of success.

More and more, the promise of EHRs transforming data into knowledge is beginning to bear fruit.

For the third consecutive year, UCSF is co-sponsoring the Precision Medicine World Conference in January 2018 to share the latest in the rapidly evolving space.

One of UCSF’s groundbreaking cancer programs will be prominently featured at the 2017 Dreamforce conference through an interactive exposition and a talk by two researchers.

Women who receive a breast cancer diagnosis while they are still young enough to bear children can take time to freeze their eggs and embryos without fear of delaying their cancer treatment.

A molecular test can pinpoint which patients will have a very low risk of death from breast cancer even 20 years after diagnosis and tumor removal, according to a new clinical study led by UCSF in collaboration with colleagues in Sweden.